1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Extended Release Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Sustained Release Drug
        1.2.3 Controlled Release Drug
    1.3 Market by Application
        1.3.1 Global Extended Release Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Extended Release Drug Market Perspective (2017-2028)
    2.2 Extended Release Drug Growth Trends by Region
        2.2.1 Extended Release Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Extended Release Drug Historic Market Size by Region (2017-2022)
        2.2.3 Extended Release Drug Forecasted Market Size by Region (2023-2028)
    2.3 Extended Release Drug Market Dynamics
        2.3.1 Extended Release Drug Industry Trends
        2.3.2 Extended Release Drug Market Drivers
        2.3.3 Extended Release Drug Market Challenges
        2.3.4 Extended Release Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Extended Release Drug Players by Revenue
        3.1.1 Global Top Extended Release Drug Players by Revenue (2017-2022)
        3.1.2 Global Extended Release Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Extended Release Drug Revenue
    3.4 Global Extended Release Drug Market Concentration Ratio
        3.4.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2021
    3.5 Extended Release Drug Key Players Head office and Area Served
    3.6 Key Players Extended Release Drug Product Solution and Service
    3.7 Date of Enter into Extended Release Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Extended Release Drug Breakdown Data by Type
    4.1 Global Extended Release Drug Historic Market Size by Type (2017-2022)
    4.2 Global Extended Release Drug Forecasted Market Size by Type (2023-2028)
5 Extended Release Drug Breakdown Data by Application
    5.1 Global Extended Release Drug Historic Market Size by Application (2017-2022)
    5.2 Global Extended Release Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Extended Release Drug Market Size (2017-2028)
    6.2 North America Extended Release Drug Market Size by Type
        6.2.1 North America Extended Release Drug Market Size by Type (2017-2022)
        6.2.2 North America Extended Release Drug Market Size by Type (2023-2028)
        6.2.3 North America Extended Release Drug Market Share by Type (2017-2028)
    6.3 North America Extended Release Drug Market Size by Application
        6.3.1 North America Extended Release Drug Market Size by Application (2017-2022)
        6.3.2 North America Extended Release Drug Market Size by Application (2023-2028)
        6.3.3 North America Extended Release Drug Market Share by Application (2017-2028)
    6.4 North America Extended Release Drug Market Size by Country
        6.4.1 North America Extended Release Drug Market Size by Country (2017-2022)
        6.4.2 North America Extended Release Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Extended Release Drug Market Size (2017-2028)
    7.2 Europe Extended Release Drug Market Size by Type
        7.2.1 Europe Extended Release Drug Market Size by Type (2017-2022)
        7.2.2 Europe Extended Release Drug Market Size by Type (2023-2028)
        7.2.3 Europe Extended Release Drug Market Share by Type (2017-2028)
    7.3 Europe Extended Release Drug Market Size by Application
        7.3.1 Europe Extended Release Drug Market Size by Application (2017-2022)
        7.3.2 Europe Extended Release Drug Market Size by Application (2023-2028)
        7.3.3 Europe Extended Release Drug Market Share by Application (2017-2028)
    7.4 Europe Extended Release Drug Market Size by Country
        7.4.1 Europe Extended Release Drug Market Size by Country (2017-2022)
        7.4.2 Europe Extended Release Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Extended Release Drug Market Size (2017-2028)
    8.2 Asia-Pacific Extended Release Drug Market Size by Type
        8.2.1 Asia-Pacific Extended Release Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Extended Release Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Extended Release Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Extended Release Drug Market Size by Application
        8.3.1 Asia-Pacific Extended Release Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Extended Release Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Extended Release Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Extended Release Drug Market Size by Region
        8.4.1 Asia-Pacific Extended Release Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Extended Release Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Extended Release Drug Market Size (2017-2028)
    9.2 Latin America Extended Release Drug Market Size by Type
        9.2.1 Latin America Extended Release Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Extended Release Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Extended Release Drug Market Share by Type (2017-2028)
    9.3 Latin America Extended Release Drug Market Size by Application
        9.3.1 Latin America Extended Release Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Extended Release Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Extended Release Drug Market Share by Application (2017-2028)
    9.4 Latin America Extended Release Drug Market Size by Country
        9.4.1 Latin America Extended Release Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Extended Release Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Extended Release Drug Market Size (2017-2028)
    10.2 Middle East & Africa Extended Release Drug Market Size by Type
        10.2.1 Middle East & Africa Extended Release Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Extended Release Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Extended Release Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Extended Release Drug Market Size by Application
        10.3.1 Middle East & Africa Extended Release Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Extended Release Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Extended Release Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Extended Release Drug Market Size by Country
        10.4.1 Middle East & Africa Extended Release Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Extended Release Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Extended Release Drug Introduction
        11.1.4 Pfizer Revenue in Extended Release Drug Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Mallinckrodt
        11.2.1 Mallinckrodt Company Details
        11.2.2 Mallinckrodt Business Overview
        11.2.3 Mallinckrodt Extended Release Drug Introduction
        11.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2017-2022)
        11.2.5 Mallinckrodt Recent Developments
    11.3 Teva
        11.3.1 Teva Company Details
        11.3.2 Teva Business Overview
        11.3.3 Teva Extended Release Drug Introduction
        11.3.4 Teva Revenue in Extended Release Drug Business (2017-2022)
        11.3.5 Teva Recent Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Extended Release Drug Introduction
        11.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Developments
    11.5 Endo Pharmaceuticals
        11.5.1 Endo Pharmaceuticals Company Details
        11.5.2 Endo Pharmaceuticals Business Overview
        11.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
        11.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2017-2022)
        11.5.5 Endo Pharmaceuticals Recent Developments
    11.6 Purdue Pharma
        11.6.1 Purdue Pharma Company Details
        11.6.2 Purdue Pharma Business Overview
        11.6.3 Purdue Pharma Extended Release Drug Introduction
        11.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2017-2022)
        11.6.5 Purdue Pharma Recent Developments
    11.7 Mylan
        11.7.1 Mylan Company Details
        11.7.2 Mylan Business Overview
        11.7.3 Mylan Extended Release Drug Introduction
        11.7.4 Mylan Revenue in Extended Release Drug Business (2017-2022)
        11.7.5 Mylan Recent Developments
    11.8 Hisamitsu Pharmaceutical
        11.8.1 Hisamitsu Pharmaceutical Company Details
        11.8.2 Hisamitsu Pharmaceutical Business Overview
        11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
        11.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2017-2022)
        11.8.5 Hisamitsu Pharmaceutical Recent Developments
    11.9 Sun Pharmaceutical Industries
        11.9.1 Sun Pharmaceutical Industries Company Details
        11.9.2 Sun Pharmaceutical Industries Business Overview
        11.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
        11.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2017-2022)
        11.9.5 Sun Pharmaceutical Industries Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Sustained Release Drug
    Table 3. Key Players of Controlled Release Drug
    Table 4. Global Extended Release Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Extended Release Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Extended Release Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Extended Release Drug Market Share by Region (2017-2022)
    Table 8. Global Extended Release Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Extended Release Drug Market Share by Region (2023-2028)
    Table 10. Extended Release Drug Market Trends
    Table 11. Extended Release Drug Market Drivers
    Table 12. Extended Release Drug Market Challenges
    Table 13. Extended Release Drug Market Restraints
    Table 14. Global Extended Release Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Extended Release Drug Revenue Share by Players (2017-2022)
    Table 16. Global Top Extended Release Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended Release Drug as of 2021)
    Table 17. Ranking of Global Top Extended Release Drug Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Extended Release Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Extended Release Drug Product Solution and Service
    Table 21. Date of Enter into Extended Release Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Extended Release Drug Revenue Market Share by Type (2017-2022)
    Table 25. Global Extended Release Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Extended Release Drug Revenue Market Share by Type (2023-2028)
    Table 27. Global Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Extended Release Drug Revenue Share by Application (2017-2022)
    Table 29. Global Extended Release Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Extended Release Drug Revenue Share by Application (2023-2028)
    Table 31. North America Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Extended Release Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Extended Release Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Extended Release Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Extended Release Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Extended Release Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Extended Release Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Extended Release Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Extended Release Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Pfizer Company Details
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Extended Release Drug Product
    Table 64. Pfizer Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 65. Pfizer Recent Developments
    Table 66. Mallinckrodt Company Details
    Table 67. Mallinckrodt Business Overview
    Table 68. Mallinckrodt Extended Release Drug Product
    Table 69. Mallinckrodt Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 70. Mallinckrodt Recent Developments
    Table 71. Teva Company Details
    Table 72. Teva Business Overview
    Table 73. Teva Extended Release Drug Product
    Table 74. Teva Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 75. Teva Recent Developments
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Extended Release Drug Product
    Table 79. Johnson & Johnson Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 80. Johnson & Johnson Recent Developments
    Table 81. Endo Pharmaceuticals Company Details
    Table 82. Endo Pharmaceuticals Business Overview
    Table 83. Endo Pharmaceuticals Extended Release Drug Product
    Table 84. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 85. Endo Pharmaceuticals Recent Developments
    Table 86. Purdue Pharma Company Details
    Table 87. Purdue Pharma Business Overview
    Table 88. Purdue Pharma Extended Release Drug Product
    Table 89. Purdue Pharma Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 90. Purdue Pharma Recent Developments
    Table 91. Mylan Company Details
    Table 92. Mylan Business Overview
    Table 93. Mylan Extended Release Drug Product
    Table 94. Mylan Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 95. Mylan Recent Developments
    Table 96. Hisamitsu Pharmaceutical Company Details
    Table 97. Hisamitsu Pharmaceutical Business Overview
    Table 98. Hisamitsu Pharmaceutical Extended Release Drug Product
    Table 99. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 100. Hisamitsu Pharmaceutical Recent Developments
    Table 101. Sun Pharmaceutical Industries Company Details
    Table 102. Sun Pharmaceutical Industries Business Overview
    Table 103. Sun Pharmaceutical Industries Extended Release Drug Product
    Table 104. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2017-2022) & (US$ Million)
    Table 105. Sun Pharmaceutical Industries Recent Developments
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Extended Release Drug Market Share by Type: 2021 VS 2028
    Figure 2. Sustained Release Drug Features
    Figure 3. Controlled Release Drug Features
    Figure 4. Global Extended Release Drug Market Share by Application: 2021 VS 2028
    Figure 5. Hospital Pharmacy Case Studies
    Figure 6. Retail Pharmacy Case Studies
    Figure 7. Online Pharmacy Case Studies
    Figure 8. Extended Release Drug Report Years Considered
    Figure 9. Global Extended Release Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Extended Release Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Extended Release Drug Market Share by Region: 2021 VS 2028
    Figure 12. Global Extended Release Drug Market Share by Players in 2021
    Figure 13. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended Release Drug as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2021
    Figure 15. North America Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Extended Release Drug Market Size Market Share by Type (2017-2028)
    Figure 17. North America Extended Release Drug Market Size Market Share by Application (2017-2028)
    Figure 18. North America Extended Release Drug Market Size Share by Country (2017-2028)
    Figure 19. United States Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Extended Release Drug Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Extended Release Drug Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Extended Release Drug Market Size Share by Country (2017-2028)
    Figure 25. Germany Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Extended Release Drug Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Extended Release Drug Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Extended Release Drug Market Size Share by Region (2017-2028)
    Figure 35. China Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Extended Release Drug Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Extended Release Drug Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Extended Release Drug Market Size Share by Country (2017-2028)
    Figure 45. Mexico Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Extended Release Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Extended Release Drug Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Extended Release Drug Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Extended Release Drug Market Size Share by Country (2017-2028)
    Figure 51. Turkey Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Extended Release Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Pfizer Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 55. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 56. Teva Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 58. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 59. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 60. Mylan Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 61. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 62. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed